Takagi H, Satoh M, Akaike A, Shibata T, Yajima H, Ogawa H
Eur J Pharmacol. 1978 May 1;49(1):113-6. doi: 10.1016/0014-2999(78)90229-7.
Methionine-enkephalin (0.2--20 microgram/rat) and leucine-enkephalin (1--20 microgram/rat) produced a dose-related and naloxone-antagonizable analgesia in the tail-pinch test, when microinjected into the nucleus reticularis gigantocellularis (NRGC) and nucleus reticularis paragigantocellularis (NRPG) of the medulla oblongata of the rat. The median analgesic doses were 1.4 and 4.8 microgram/rat for methionine- leucine-enkephalin, respectively. The possibility that the endogenous enkephalins play a part as pain control substances or modulators in the NRGC and NRPG was discussed.
当向大鼠延髓的巨细胞网状核(NRGC)和旁巨细胞网状核(NRPG)微量注射蛋氨酸脑啡肽(0.2 - 20微克/大鼠)和亮氨酸脑啡肽(1 - 20微克/大鼠)时,在夹尾试验中产生了剂量相关且可被纳洛酮拮抗的镇痛作用。蛋氨酸 - 亮氨酸脑啡肽的半数镇痛剂量分别为1.4和4.8微克/大鼠。讨论了内源性脑啡肽在NRGC和NRPG中作为疼痛控制物质或调节剂发挥作用的可能性。